Aquestive Therapeutics
0 followers
Aquestive Therapeutics, Inc. is a specialty pharmaceutical company. The Company is focused on the development of treatments for diseases related to the central nervous system (CNS). Its CNS programs consist of a pipeline of products that include Libervant, Sympazan, and AQST-117.
Org chart
Daniel Barber
CEO, President & Director
Daniel Barber
Collapse
Mark Schobel
Chief Innovation & Technology Officer
Ernie Toth
CFO
Carl Kraus
Chief Medical Officer
Lori J. Braender
SVP, General Counsel
Cassie Jung
SVP, Operations
Stephen Wargacki
SVP, Research & Development
Amy Santos
Vice President, Global Quality Assurance
Patricia Lasquinha
Office Manager/executive Assistant Ceo/cito
Joseph Crusco
Director Business Development
Teams
View all
